Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Parecoxib (SC 69124) is an effective and selective COX-2 inhibitor.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 7,000 | |||
25 mg | 在庫あり | ¥ 11,000 | |||
50 mg | 在庫あり | ¥ 17,000 | |||
100 mg | 在庫あり | ¥ 28,500 | |||
200 mg | 在庫あり | ¥ 41,000 | |||
500 mg | 在庫あり | ¥ 68,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 12,500 |
説明 | Parecoxib (SC 69124) is an effective and selective COX-2 inhibitor. |
In vivo | Parecoxib, a selected cyclooxygenase-2 inhibitor, ameliorates neurologic deficits in the behavior studies and brain damage, including neuronal death, and brain edema in the MCP-1 and NeuN immunostaining in rats subjected to SAH(Subarachnoid Hemorrhage). Parecoxib is able to reduce early COX2 expression via inhibiting cJNK (p55) expression (dose-dependently), reduce IL-1β, IL-6 and MCP-1( at 2000 ug/kg/day at the time point of 24hr and 72hr after the induction of SAH), IL-8 (of the dosage of 2000 ug/kg/day at 24hr after the induction of SAH), and also reduce cleaved caspase-1 (at 1000 and 2000 ug/kg/day) and Caspase-9a (at 2000 ug/kg/day). Parecoxib reduces the NMDAR-1, and NMDAR-2a (at 1000 and 2000 ug/kg) after the induction of SAH[2]. |
別名 | SC 69124, Vorth-P, Valus-P |
分子量 | 370.42 |
分子式 | C19H18N2O4S |
CAS No. | 198470-84-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 2 mg/mL (5.4 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 50 mg/mL (134.98 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Parecoxib 198470-84-7 Immunology/Inflammation Neuroscience COX osteoarthritis POCD rheumatoid arthritis pain Cyclooxygenase cognitive dysfunction postoperative SC 69124 SC-69124 coxibs analgesia SC69124 Inhibitor inhibit Vorth-P chronic inflammatory condition Valus-P inhibitor